File S1 - Post-Stroke Mortality, Stroke Severity, and Preadmission Antipsychotic Medicine Use – A Population-Based Cohort Study

File includes Supporting Tables S1–S12. Supporting Table S1: Association between preadmission antipsychotic medication use and length of hospital stay in a competing risk set-up. Supporting Table S2: Association between preadmission antipsychotic medication use and 30-day mortality in acute stroke stratified by age. Supporting Table S3: Association between preadmission antipsychotic medication use and 30-day mortality in acute stroke stratified by type of stroke and stroke severity on the Scandinavian Stroke Scale. Supporting Table S4: Association between preadmission antipsychotic medication use and 30-day mortality stratified by former stroke. Supporting Table S5: Association between preadmission antipsychotic medication use and 30-day mortality stratified by former neurological disorder. Supporting Table S6: Association between preadmission antipsychotic medication use and 30-day mortality stratified by a diagnosis of diabetes. Supporting Table S7: Association between preadmission antipsychotic medication use and 30-day mortality stratified by preadmission anti-dementia medication use. Supporting Table S8: Association between preadmission antipsychotic medication use and 30-day mortality in acute stroke according to typical versus atypical antipsychotics use. Supporting Table S9: Association between preadmission antipsychotic medication use and 30-day mortality in users having filled three or more prescriptions before admission for acute stroke. Supporting Table S10: Association between quality of in-hospital care, preadmission antipsychotic medication use and 30-day mortality. Supporting Table S11: Association between antipsychotic medication use and 30-day mortality in complete-case analyses of alcohol and tobacco use. Supporting Table S12: Association between preadmission antipsychotic medication use and 30-day mortality. Propensity score matching analysis. (PDF)